Comment on "Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes": Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations

Research output: Contribution to journalComment/debateScientific

Original languageEnglish
Article number1805199
JournalSmall
Volume15
Issue number15
Number of pages2
ISSN1613-6810
DOIs
Publication statusPublished - Apr 2019
MoE publication typeB1 Journal article

Fields of Science

  • bevacizumab
  • liposomes
  • retinal delivery
  • topical eyedrops
  • 317 Pharmacy

Cite this

@article{f3fe34f04ea14c89977623bf3341a7ac,
title = "Comment on {"}Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes{"}: Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations",
keywords = "bevacizumab, liposomes, retinal delivery, topical eyedrops, 317 Pharmacy",
author = "Arto Urtti",
year = "2019",
month = "4",
doi = "10.1002/smll.201805199",
language = "English",
volume = "15",
journal = "Small",
issn = "1613-6810",
publisher = "Wiley-VCH",
number = "15",

}

TY - JOUR

T1 - Comment on "Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes"

T2 - Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations

AU - Urtti, Arto

PY - 2019/4

Y1 - 2019/4

KW - bevacizumab

KW - liposomes

KW - retinal delivery

KW - topical eyedrops

KW - 317 Pharmacy

U2 - 10.1002/smll.201805199

DO - 10.1002/smll.201805199

M3 - Comment/debate

VL - 15

JO - Small

JF - Small

SN - 1613-6810

IS - 15

M1 - 1805199

ER -